- GlobeNewswire•10 hours ago
ZIOPHARM Announces Successful End-of-Phase 2 Meeting with FDA for Ad-RTS-hIL-12 Gene Therapy in Recurrent Glioblastoma
BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the receipt of positive guidance from an End-of-Phase 2 meeting with the U.S. ...
- GlobeNewswire•11 hours ago
BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the appointment of Amy Trevvett as Vice President of Investor Relations and ...
- Motley Fool•5 days ago
Motley Fool contributors have considered the obstacles facing Casey's General Stores, Zoe's Kitchen, and Intrexon Corp. and concluded their share prices have become too rich.
XON : Summary for Intrexon Corporation Common Sto - Yahoo Finance
Intrexon Corporation (XON)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||18.86 - 20.14|
|52 Week Range||18.55 - 38.60|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.65|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|